(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Marathon, Canaan, and Secoo Holding Limited.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Marathon (MARA) | 21.60 | 23.12% | 2024-02-08 15:59:59 |
| 2 | Canaan (CAN) | 1.53 | 19.14% | 2024-02-08 15:47:47 |
| 3 | Secoo Holding Limited (SECO) | 0.51 | 18.98% | 2024-02-08 11:13:06 |
| 4 | Viking Therapeutics (VKTX) | 28.87 | 17.93% | 2024-02-08 15:50:16 |
| 5 | MicroStrategy (MSTR) | 587.82 | 15.71% | 2024-02-08 15:59:26 |
| 6 | Riot Blockchain (RIOT) | 12.97 | 14.58% | 2024-02-08 15:49:31 |
| 7 | Monolithic Power Systems (MPWR) | 737.78 | 14.31% | 2024-02-08 15:50:47 |
| 8 | Pall Corporation (PLL) | 14.49 | 13.38% | 2024-02-07 21:14:06 |
| 9 | REGENXBIO (RGNX) | 14.57 | 11.65% | 2024-02-08 05:13:05 |
| 10 | Walt Disney (DIS) | 110.24 | 11.2% | 2024-02-08 15:54:46 |
The three biggest losers today are Phunware, Poseida Therapeutics, and PayPal.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Phunware (PHUN) | 0.34 | -14.5% | 2024-02-07 19:49:06 |
| 2 | Poseida Therapeutics (PSTX) | 3.33 | -12.27% | 2024-02-08 01:09:06 |
| 3 | PayPal (PYPL) | 55.81 | -11.74% | 2024-02-08 15:49:26 |
| 4 | GoPro (GPRO) | 2.58 | -11.08% | 2024-02-08 15:59:06 |
| 5 | Rekor Systems (REKR) | 2.69 | -10.33% | 2024-02-08 04:44:05 |
| 6 | Snap (SNA) | 266.32 | -9.57% | 2024-02-08 15:59:45 |
| 7 | FleetCor Technologies (FLT) | 264.75 | -9.33% | 2024-02-08 15:52:55 |
| 8 | PLUS THERAPEUTICS (PSTV) | 1.94 | -7.62% | 2024-02-08 01:08:06 |
| 9 | Arcadia Biosciences (RKDA) | 2.45 | -7.55% | 2024-02-08 07:12:06 |
| 10 | RumbleOn (RMBL) | 6.40 | -7.38% | 2024-02-08 07:17:06 |
Winners today
1. Marathon (MARA) – 23.12%
Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines digital assets with a focus on the blockchain ecosystem and the generation of digital assets in United States. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Fort Lauderdale, Florida.
NASDAQ ended the session with Marathon rising 23.12% to $21.60 on Thursday, after two consecutive sessions in a row of gains. NASDAQ jumped 0.24% to $15,793.71, after two sequential sessions in a row of gains, on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, Marathon has a trailing twelve months EPS of $-3.08.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.13%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Marathon’s EBITDA is 17.65.
Yearly Top and Bottom Value
Marathon’s stock is valued at $21.60 at 16:32 EST, way below its 52-week high of $31.30 and way above its 52-week low of $5.13.
Sales Growth
Marathon’s sales growth is 381.8% for the ongoing quarter and 235.1% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 98.1% and 280%, respectively.
More news about Marathon.
2. Canaan (CAN) – 19.14%
Canaan Inc. engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts. The company has operations in the United States, Australia, Kazakhstan, Hong Kong, Canada, Mainland China, Thailand, Sweden, and internationally. Canaan Inc. was founded in 2013 and is based in Singapore.
NASDAQ ended the session with Canaan rising 19.14% to $1.53 on Thursday, after two successive sessions in a row of gains. NASDAQ jumped 0.24% to $15,793.71, after two successive sessions in a row of gains, on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, Canaan has a trailing twelve months EPS of $-0.47.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.23%.
Sales Growth
Canaan’s sales growth is negative 39% for the current quarter and negative 21% for the next.
Yearly Top and Bottom Value
Canaan’s stock is valued at $1.53 at 16:32 EST, way under its 52-week high of $3.98 and way higher than its 52-week low of $1.13.
Revenue Growth
Year-on-year quarterly revenue growth declined by 75.1%, now sitting on 160.89M for the twelve trailing months.
More news about Canaan.
3. Secoo Holding Limited (SECO) – 18.98%
Secoo Holding Limited, through its subsidiaries, operates an integrated online and offline shopping platform in the People's Republic of China, Hong Kong, and internationally. It provides upscale brand products and services, including handbags, watches, clothing, footwear, jewelry and accessories, cosmetics and skincare, home accessories, sportswear, home goods, fine food and beverage products, arts, 3C electronic devices, and Chinese original products, as well as lifestyle services through its website, mobile applications, and offline experience centers. The company also offers its website as a marketplace to third party merchants to facilitate their sales of upscale products and services. Secoo Holding Limited was incorporated in 2011 and is headquartered in Beijing, China.
NASDAQ ended the session with Secoo Holding Limited rising 18.98% to $0.51 on Thursday while NASDAQ rose 0.24% to $15,793.71.
Earnings Per Share
As for profitability, Secoo Holding Limited has a trailing twelve months EPS of $-26.63.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -84.14%.
More news about Secoo Holding Limited.
4. Viking Therapeutics (VKTX) – 17.93%
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
NASDAQ ended the session with Viking Therapeutics jumping 17.93% to $28.87 on Thursday, after two successive sessions in a row of losses. NASDAQ jumped 0.24% to $15,793.71, after two sequential sessions in a row of gains, on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, Viking Therapeutics has a trailing twelve months EPS of $-0.92.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -31.12%.
More news about Viking Therapeutics.
5. MicroStrategy (MSTR) – 15.71%
MicroStrategy Incorporated provides enterprise analytics software and services in the United States, Canada, Europe, the Middle East, Africa, and internationally. It offers MicroStrategy, an enterprise analytics software platform that enables users to create visualizations, customize apps, and embed analytics directly into workflows; and MicroStrategy Cloud Environment, a managed software-as-a-service solution, which offers always-on threat monitoring and enables rapid analytics development and deployment to deliver security and data privacy requirements. The company also provides MicroStrategy Support that helps customers to achieve their system availability and uptime goals, and to improve the overall experience through highly responsive troubleshooting and proactive technical product support. In addition, it offers MicroStrategy Consulting, which offers customers with architecture and implementation services to help them quickly realize results, as well as helps to achieve returns on investment derived from understanding of data; and MicroStrategy Education that provides free and paid learning options, as well as holds and acquires bitcoin. The company offers its services through enterprise sales force and channel partners. It serves companies from a range of industries, including banking, technology, consulting, manufacturing, insurance, healthcare, and telecommunications, as well as the public sector. The company was incorporated in 1989 and is headquartered in Tysons Corner, Virginia.
NASDAQ ended the session with MicroStrategy jumping 15.71% to $587.82 on Thursday while NASDAQ rose 0.24% to $15,793.71.
Earnings Per Share
As for profitability, MicroStrategy has a trailing twelve months EPS of $2.03.
PE Ratio
MicroStrategy has a trailing twelve months price to earnings ratio of 289.57. Meaning, the purchaser of the share is investing $289.57 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.22%.
Sales Growth
MicroStrategy’s sales growth is 0.3% for the ongoing quarter and 4.8% for the next.
Yearly Top and Bottom Value
MicroStrategy’s stock is valued at $587.82 at 16:32 EST, way under its 52-week high of $727.77 and way higher than its 52-week low of $188.30.
Revenue Growth
Year-on-year quarterly revenue growth grew by 3.3%, now sitting on 504.33M for the twelve trailing months.
More news about MicroStrategy.
6. Riot Blockchain (RIOT) – 14.58%
Riot Platforms, Inc., together with its subsidiaries, operates as a bitcoin mining company in North America. It operates through Bitcoin Mining, Data Center Hosting, and Engineering segments. The company also provides co-location services for institutional-scale bitcoin mining companies; and critical infrastructure and workforce for institutional-scale miners to deploy and operate their miners. In addition, it engages in the design and manufacturing of power distribution equipment and custom engineered electrical products; electricity distribution product design, manufacture, and installation services primarily focused on large-scale commercial and governmental customers, as well as a range of markets, including data center, power generation, utility, water, industrial, and alternative energy; operation of data centers; and maintenance/management of computing capacity. The company was formerly known as Riot Blockchain, Inc. Riot Platforms, Inc. was incorporated in 1998 and is based in Castle Rock, Colorado.
NASDAQ ended the session with Riot Blockchain jumping 14.58% to $12.97 on Thursday, after two successive sessions in a row of gains. NASDAQ jumped 0.24% to $15,793.71, after two consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, Riot Blockchain has a trailing twelve months EPS of $-1.8.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.88%.
Volume
Today’s last reported volume for Riot Blockchain is 28555800 which is 2.71% below its average volume of 29352800.
More news about Riot Blockchain.
7. Monolithic Power Systems (MPWR) – 14.31%
Monolithic Power Systems, Inc. engages in the design, development, marketing, and sale of semiconductor-based power electronics solutions for the computing and storage, automotive, industrial, communications, and consumer markets. The company provides direct current (DC) to DC integrated circuits (ICs) that are used to convert and control voltages of various electronic systems, such as portable electronic devices, wireless LAN access points, computers and notebooks, monitors, infotainment applications, and medical equipment. It also offers lighting control ICs for backlighting that are used in systems, which provide the light source for LCD panels in notebook computers, monitors, car navigation systems, and televisions, as well as for general illumination products. The company sells its products through third-party distributors and value-added resellers, as well as directly to original equipment manufacturers, original design manufacturers, electronic manufacturing service providers, and other end customers in China, Taiwan, Europe, South Korea, Southeast Asia, Japan, the United States, and internationally. Monolithic Power Systems, Inc. was incorporated in 1997 and is based in Kirkland, Washington.
NASDAQ ended the session with Monolithic Power Systems jumping 14.31% to $737.78 on Thursday while NASDAQ jumped 0.24% to $15,793.71.
Earnings Per Share
As for profitability, Monolithic Power Systems has a trailing twelve months EPS of $8.78.
PE Ratio
Monolithic Power Systems has a trailing twelve months price to earnings ratio of 84.03. Meaning, the purchaser of the share is investing $84.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.87%.
Moving Average
Monolithic Power Systems’s worth is way above its 50-day moving average of $596.51 and way higher than its 200-day moving average of $516.12.
Volume
Today’s last reported volume for Monolithic Power Systems is 1293060 which is 181.77% above its average volume of 458893.
More news about Monolithic Power Systems.
8. Pall Corporation (PLL) – 13.38%
Piedmont Lithium Inc., an exploration stage company, engages in the exploration and development of resource projects in the United States. The company primarily holds a 100% interest in the Carolina Lithium Project that include an area of approximately 3,116 acres located within the Carolina Tin-Spodumene Belt situated to the west of Charlotte, North Carolina in the United States. It also owns a 61-acre property in Kings Mountain, North Carolina. Piedmont Lithium Inc. is headquartered in Belmont, North Carolina.
NASDAQ ended the session with Pall Corporation jumping 13.38% to $14.49 on Thursday while NASDAQ jumped 0.24% to $15,793.71.
Earnings Per Share
As for profitability, Pall Corporation has a trailing twelve months EPS of $-0.43.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.3%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Pall Corporation’s EBITDA is 26.98.
More news about Pall Corporation.
9. REGENXBIO (RGNX) – 11.65%
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's lead product candidate is RGX-314, which is in Phase III clinical trial for the treatment of wet age-related macular degeneration. It is also developing RGX-121 that is in Phase I/II clinical trial to treat mucopolysaccharidosis type II;RGX-111, which is in Phase I/II clinical trial for treating mucopolysaccharidosis type I;RGX-181 which is in pre clinic stage for the treatment of late-infantile neuronal ceroid lipofuscinosis type II disease;RGX-202, to treat Duchenne muscular dystrophy which is in phase I/II clinical trial; and RGX-381, to treat the ocular manifestations of CLN2 disease which is in preclinical stage. REGENXBIO Inc. also licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies; and has a collaboration and license agreement with Neurimmune AG to develop novel gene therapies. REGENXBIO Inc. was founded in 2008 and is headquartered in Rockville, Maryland.
NASDAQ ended the session with REGENXBIO rising 11.65% to $14.57 on Thursday, after three successive sessions in a row of gains. NASDAQ jumped 0.24% to $15,793.71, after two consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, REGENXBIO has a trailing twelve months EPS of $-5.99.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -56.22%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.1%, now sitting on 99.37M for the twelve trailing months.
Moving Average
REGENXBIO’s value is way below its 50-day moving average of $16.79 and way below its 200-day moving average of $17.80.
Sales Growth
REGENXBIO’s sales growth is 14.8% for the present quarter and 46.7% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
REGENXBIO’s EBITDA is -8.86.
More news about REGENXBIO.
10. Walt Disney (DIS) – 11.2%
The Walt Disney Company operates as an entertainment company worldwide. It operates through three segments: Entertainment, Sports, and Experiences. The company produces and distributes film and television video streaming content under the ABC Television Network, Disney, Freeform, FX, Fox, National Geographic, and Star brand television channels, as well as ABC television stations and A+E television networks; and produces original content under the ABC Signature, Disney Branded Television, FX Productions, Lucasfilm, Marvel, National Geographic Studios, Pixar, Searchlight Pictures, Twentieth Century Studios, 20th Television, and Walt Disney Pictures banners. It also offers direct-to-consumer streaming services through Disney+, Disney+ Hotstar, Hulu, and Star+; sports-related entertainment services through ESPN, ESPN on ABC, ESPN+ DTC, and Star; sale/licensing of film and episodic content to third-party television and VOD services; theatrical, home entertainment, and music distribution services; DVD and Blu-ray discs, electronic home video licenses, and VOD rental services; staging and licensing of live entertainment events; and post-production services. In addition, the company operates theme parks and resorts comprising Walt Disney World Resort, Disneyland Resort, Disneyland Paris, Hong Kong Disneyland Resort, Shanghai Disney Resort, Disney Cruise Line, Disney Vacation Club, National Geographic Expeditions, and Adventures by Disney, as well as Aulani, a Disney resort and spa in Hawaii. It also licenses its intellectual property to a third party for operations of the Tokyo Disney Resort; licenses trade names, characters, visual, literary, and other IP for use on merchandise, published materials, and games; operates a direct-to-home satellite distribution platform; sells branded merchandise through retail, online, and wholesale businesses; and develops and publishes books, comic books, and magazines. The company was founded in 1923 and is based in Burbank, California.
NYSE ended the session with Walt Disney jumping 11.2% to $110.24 on Thursday while NYSE jumped 0.16% to $17,240.19.
Earnings Per Share
As for profitability, Walt Disney has a trailing twelve months EPS of $1.63.
PE Ratio
Walt Disney has a trailing twelve months price to earnings ratio of 67.63. Meaning, the purchaser of the share is investing $67.63 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.06%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Walt Disney’s EBITDA is 63.09.
Volume
Today’s last reported volume for Walt Disney is 56199900 which is 334.77% above its average volume of 12926100.
More news about Walt Disney.
Losers Today
1. Phunware (PHUN) – -14.5%
Phunware, Inc., together with its subsidiaries, offers integrated software platform that equips companies with the products, solutions, and services to engage, manage, and monetize their mobile application portfolios in the United States and internationally. The company's products and services include cloud-based mobile software that licenses in software development kits (SDKs) form utilized inside mobile applications, such as analytics that provides data related to application use and engagement; content management that allows application administrators to create and manage app content in a cloud-based portal; alerts, notifications, and messaging; marketing automation that enables location-triggered messages and workflow; advertising; and location-based services that include mapping, navigation, wayfinding, workflow, asset management, and policy enforcement. It also engages the integration of its SDK licenses into existing applications maintained by its customers, as well as custom application development and support services; provision of cloud-based vertical solutions for healthcare, retail, sports, aviation, real estate, hospitality, education, and other applications; offering application transactions, including re-occurring and one-time transactional media purchases for application discovery, user acquisition and audience building, audience engagement, and audience monetization; and pre-packaged and custom high-end personal computer systems for gaming, streaming, and cryptocurrency mining enthusiasts. The company was founded in 2009 and is headquartered in Austin, Texas.
NASDAQ ended the session with Phunware dropping 14.5% to $0.34 on Thursday, after two consecutive sessions in a row of losses. NASDAQ jumped 0.24% to $15,793.71, after two successive sessions in a row of gains, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, Phunware has a trailing twelve months EPS of $-0.37.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -206.72%.
Volume
Today’s last reported volume for Phunware is 148602000 which is 38.94% above its average volume of 106953000.
More news about Phunware.
2. Poseida Therapeutics (PSTX) – -12.27%
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). It is also developing P-BCMA-ALLO1, which is in Phase I trial to treat patients with relapsed/refractory multiple myeloma; and P-MUC1C-ALLO1 that is in Phase I trial for treating a range of solid tumors, including breast, ovarian, and other epithelial-derived cancers. In addition, the company engages in the development of P-CD19CD20-ALLO1 for B cell malignancies and other autoimmune diseases; and P-BCMACD19-ALLO1, an allogeneic, off-the-shelf CAR-T product candidate in preclinical development for multiple myeloma. Further, it is developing P-PSMA-ALLO1, an allogeneic CAR-T product candidate for treating mCRPC. Additionally, the company engages in the development of P-OTC-101 and P-FVIII-101 that are clinical stage liver-directed gene therapies; and other allogeneic dual CAR candidates. It has a research collaboration and license agreement with Takeda Pharmaceutical Company Limited. The company was incorporated in 2014 and is headquartered in San Diego, California.
NASDAQ ended the session with Poseida Therapeutics falling 12.27% to $3.33 on Thursday, following the last session’s downward trend. NASDAQ jumped 0.24% to $15,793.71, after two consecutive sessions in a row of gains, on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, Poseida Therapeutics has a trailing twelve months EPS of $-1.54.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -77.3%.
Yearly Top and Bottom Value
Poseida Therapeutics’s stock is valued at $3.33 at 16:32 EST, way under its 52-week high of $8.57 and way higher than its 52-week low of $1.54.
Volume
Today’s last reported volume for Poseida Therapeutics is 871320 which is 9.22% below its average volume of 959881.
More news about Poseida Therapeutics.
3. PayPal (PYPL) – -11.74%
PayPal Holdings, Inc. operates a technology platform that enables digital payments on behalf of merchants and consumers worldwide. The company provides payment solutions under the PayPal, PayPal Credit, Braintree, Venmo, Xoom, PayPal Zettle, Hyperwallet, PayPal Honey, and Paidy names. Its payments platform allows consumers to send and receive payments in approximately 200 markets and in approximately 150 currencies, withdraw funds to their bank accounts in 56 currencies, and hold balances in their PayPal accounts in 25 currencies. The company was founded in 1998 and is headquartered in San Jose, California.
NASDAQ ended the session with PayPal sliding 11.74% to $55.81 on Thursday, following the last session’s downward trend. NASDAQ jumped 0.24% to $15,793.71, after two consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.
PayPal (pypl) Q4 earnings beat estimates, revenues up y/yPayPal Holdings, Inc. price-consensus-eps-surprise-chart | PayPal Holdings, Inc. Quote, For 2024, PayPal anticipates non-GAAP earnings to be in line with the reported figure in 2023.
Earnings Per Share
As for profitability, PayPal has a trailing twelve months EPS of $3.35.
PE Ratio
PayPal has a trailing twelve months price to earnings ratio of 16.66. Meaning, the purchaser of the share is investing $16.66 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.82%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 9.7% and 8.5%, respectively.
More news about PayPal.
4. GoPro (GPRO) – -11.08%
GoPro, Inc. develops and sells cameras, mountable and wearable accessories, and subscription services and software in the Americas, Europe, the Middle East, Africa, the Asia and Pacific region, and internationally. The company provides cloud connected HERO11 Black, HERO11 Black Mini, HERO10 Black, HERO10 Black Bones, HERO9 Black, and HERO8 Black waterproof cameras; MAX, a 360-degree waterproof camera; GoPro, a subscription service that includes full access to the Quik app, cloud storage supporting source video and photo quality, camera replacement, and damage protection; Quik subscription offers access to editing tools, which allows users to edit photos, videos, and create cinematic stories; and Quik app, a mobile app that enable users to get their favorite photos and videos with footage from any phone or camera. It also offers mounts and accessories comprising equipment-based mounts consisting of helmet, handlebar, roll bar, and tripod mounts that enable consumers to wear the mount on their bodies, such as wrist housings, magnetic swivel clips, chest harnesses, and head straps; media, display, and light mods; spare batteries, dive filters, and charging accessories and cables; and lifestyle gears. In addition, the company provides mobile and web applications that provides media workflow for archiving, editing, multi-clip story creation, and sharing content on the fly. GoPro, Inc. markets and sells its products through retailers and wholesale distributors, as well as through its GoPro.com website. The company was formerly known as Woodman Labs, Inc. and changed its name to GoPro, Inc. in February 2014. GoPro, Inc. was founded in 2002 and is headquartered in San Mateo, California.
NASDAQ ended the session with GoPro dropping 11.08% to $2.58 on Thursday while NASDAQ rose 0.24% to $15,793.71.
Earnings Per Share
As for profitability, GoPro has a trailing twelve months EPS of $-0.31.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.18%.
More news about GoPro.
5. Rekor Systems (REKR) – -10.33%
Rekor Systems, Inc., through its subsidiaries, develops and implements transformative mission-critical intelligent infrastructure solutions and services for transportation management, public safety, and commercial markets in the United States, Canada, and internationally. It offers Rekor One Traffic Management solutions, including software modules for roadway monitoring and response, an incident detection and management solution; traffic and infrastructure analytics to capture data for roadway and infrastructure analytics and planning; and live and archival traffic view for situational awareness of what is happening on roadways. The company also provides Rekor One Public Safety solutions comprising contactless compliance application that delivers a turnkey information and citation management solution to cities, states, and municipalities for primary and secondary offenses; Rekor scout that offers accurate license plate and vehicle recognition on any IP, traffic, or security camera, and can be subscribed to separately for use with existing camera or sensor systems; and Rekor blue, a smartphone app that retrieves accurate vehicle license plate number and state of registration, and automatically organizes information by sessions, capturing date, location, and timestamp for law enforcement. In addition, it offers Rekor CarCheck, an API of its vehicle recognition technology to respond with accurate license plate data, vehicle make, model, body type, and color for commercial applications; and AutoNotice, a cloud-based financial management application to record payments in the system and provide functionality to research, manage unapplied payments, and reconcile receipts. Further, the company provides hardware products, which includes Rekor Edge Series, a family of mountable vehicle recognition systems that seamlessly capture and process vehicle data. Rekor Systems, Inc. was founded in 2017 and is headquartered in Columbia, Maryland.
NASDAQ ended the session with Rekor Systems sliding 10.33% to $2.69 on Thursday, after four consecutive sessions in a row of losses. NASDAQ rose 0.24% to $15,793.71, after two sequential sessions in a row of gains, on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, Rekor Systems has a trailing twelve months EPS of $-0.66.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -84.19%.
Volume
Today’s last reported volume for Rekor Systems is 3684560 which is 304.87% above its average volume of 910058.
More news about Rekor Systems.
6. Snap (SNA) – -9.57%
Snap-on Incorporated manufactures and markets tools, equipment, diagnostics, and repair information and systems solutions for professional users worldwide. It operates through Commercial & Industrial Group, Snap-on Tools Group, Repair Systems & Information Group, and Financial Services segments. The company provides hand tools, including wrenches, sockets, ratchet wrenches, pliers, screwdrivers, punches and chisels, saws and cutting tools, pruning tools, torque measuring instruments, and other related products; power tools, such as cordless, pneumatic, and hydraulic and corded tools; and tool storage products comprising tool chests, roll cabinets, and other products. It also provides handheld and computer-based diagnostic products, service and repair information products, diagnostic software solutions, electronic parts catalogs, business management systems and services, point-of-sale systems, integrated systems for vehicle service shops, original equipment manufacturer purchasing facilitation services, and warranty management systems and analytics; and engineered solutions. In addition, the company offers solutions for the service of vehicles and industrial equipment that include wheel alignment equipment, wheel balancers, tire changers, vehicle lifts, test lane equipment, collision repair equipment, vehicle air conditioning service equipment, brake service equipment, fluid exchange equipment, transmission troubleshooting equipment, safety testing equipment, battery chargers, and hoists, as well as after-sales support services and training programs. Further, it provides financing programs to facilitate the sales of its products and support its franchise business. The company serves the aviation and aerospace, agriculture, infrastructure construction, government and military, mining, natural resources, power generation, and technical education industries Snap-on Incorporated was founded in 1920 and is headquartered in Kenosha, Wisconsin.
NYSE ended the session with Snap falling 9.57% to $266.32 on Thursday while NYSE rose 0.16% to $17,240.19.
Earnings Per Share
As for profitability, Snap has a trailing twelve months EPS of $18.41.
PE Ratio
Snap has a trailing twelve months price to earnings ratio of 14.47. Meaning, the purchaser of the share is investing $14.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.15%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Nov 19, 2023, the estimated forward annual dividend rate is 7.44 and the estimated forward annual dividend yield is 2.59%.
Sales Growth
Snap’s sales growth is 4% for the ongoing quarter and 2.7% for the next.
Previous days news about Snap
- Snap (snap) tops Q4 earnings estimates. According to Zacks on Tuesday, 6 February, "While Snap has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
- Snap (snap) reports Q4 earnings: what key metrics have to say. According to Zacks on Wednesday, 7 February, "Here is how Snap performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
More news about Snap.
7. FleetCor Technologies (FLT) – -9.33%
FLEETCOR Technologies, Inc., a business payments company that helps businesses spend less by enabling them to manage their expense-related purchasing and vendor payments processes. It offers corporate payments solutions, such as accounts payable automation; Virtual Card, which provides a single-use card number for a specific amount usable within a defined timeframe; Cross-Border that is used by its customers to pay international vendors, foreign office and personnel expenses, capital expenditures, and profit repatriation and dividends; and purchasing cards and travel and entertainment cards for its customers to analyze and manage their corporate spending. The company also provides vehicle and mobility solutions, including fuel solutions to businesses and government entities that operate vehicle fleets, as well as to oil and leasing companies, and fuel marketers; lodging solutions to businesses that have employees who travel overnight for work purposes, as well as to airlines and cruise lines to accommodate traveling crews and stranded passengers; and electronic toll payments solutions to businesses and consumers in the form of radio frequency identification tags affixed to vehicles' windshields. In addition, it offers gift card program management and processing services in plastic and digital forms that include card design, production and packaging, delivery and fulfillment, card and account management, transaction processing, promotion development and management, website design and hosting, program analytics, and card distribution channel management. Further, the company provides other products consisting of payroll cards, vehicle maintenance service solution, long-haul transportation solution, prepaid food vouchers or cards, and prepaid transportation cards and vouchers. It serves business, merchant, consumer, and payment network customers in North America, Brazil, and Internationally. The company was founded in 1986 and is headquartered in Atlanta, Georgia.
NYSE ended the session with FleetCor Technologies sliding 9.33% to $264.75 on Thursday while NYSE jumped 0.16% to $17,240.19.
Earnings Per Share
As for profitability, FleetCor Technologies has a trailing twelve months EPS of $12.76.
PE Ratio
FleetCor Technologies has a trailing twelve months price to earnings ratio of 20.75. Meaning, the purchaser of the share is investing $20.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 35.99%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.7%, now sitting on 3.7B for the twelve trailing months.
Volatility
FleetCor Technologies’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.87%, a negative 0.06%, and a positive 1.07%.
FleetCor Technologies’s highest amplitude of average volatility was 1.19% (last week), 1.15% (last month), and 1.07% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FleetCor Technologies’s stock is considered to be overbought (>=80).
Previous days news about FleetCor Technologies
- Fleetcor technologies (flt) Q4 earnings and revenues miss estimates. According to Zacks on Wednesday, 7 February, "While FleetCor Technologies has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
- Here's what key metrics tell us about fleetcor technologies (flt) Q4 earnings. According to Zacks on Wednesday, 7 February, "Here is how FleetCor Technologies performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
More news about FleetCor Technologies.
8. PLUS THERAPEUTICS (PSTV) – -7.62%
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It has a license agreement with NanoTx, Corp. to develop and commercialize NanoTx's glioblastoma treatment. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.
NASDAQ ended the session with PLUS THERAPEUTICS sliding 7.62% to $1.94 on Thursday while NASDAQ rose 0.24% to $15,793.71.
Earnings Per Share
As for profitability, PLUS THERAPEUTICS has a trailing twelve months EPS of $-5.87.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -216.23%.
Yearly Top and Bottom Value
PLUS THERAPEUTICS’s stock is valued at $1.94 at 16:32 EST, way under its 52-week high of $6.15 and way higher than its 52-week low of $0.97.
More news about PLUS THERAPEUTICS.
9. Arcadia Biosciences (RKDA) – -7.55%
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was incorporated in 2002 and is headquartered in Davis, California.
NASDAQ ended the session with Arcadia Biosciences dropping 7.55% to $2.45 on Thursday, following the last session’s downward trend. NASDAQ jumped 0.24% to $15,793.71, after two sequential sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, Arcadia Biosciences has a trailing twelve months EPS of $-21.41.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -91.57%.
Sales Growth
Arcadia Biosciences’s sales growth is 75% for the current quarter and 19.3% for the next.
Yearly Top and Bottom Value
Arcadia Biosciences’s stock is valued at $2.45 at 16:32 EST, way below its 52-week high of $18.94 and higher than its 52-week low of $2.33.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 59% and 78.9%, respectively.
More news about Arcadia Biosciences.
10. RumbleOn (RMBL) – -7.38%
RumbleON, Inc. operates a technology-based omnichannel platform to aggregate and distribute pre-owned vehicles in North America. It operates through three segments: Powersports, Automotive, and Vehicle Logistics. The Powersports segment distributes motorcycles. The Automotive segment distributes cars and trucks. The Vehicle Logistics segment provides automotive transportation services between dealerships and auctions. Its platform offers ability to buy, sell, trade, and finance new and pre-owned vehicles online or in store for dealers and consumers. The company was formerly known as Smart Server, Inc. and changed its name to RumbleON, Inc. in February 2017. RumbleON, Inc. was incorporated in 2013 and is based in Irving, Texas.
NASDAQ ended the session with RumbleOn sliding 7.38% to $6.40 on Thursday while NASDAQ jumped 0.24% to $15,793.71.
Earnings Per Share
As for profitability, RumbleOn has a trailing twelve months EPS of $-20.98.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -100.33%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
RumbleOn’s EBITDA is 115.78.
Sales Growth
RumbleOn’s sales growth is negative 8.1% for the present quarter and 8.2% for the next.
Moving Average
RumbleOn’s worth is below its 50-day moving average of $7.01 and way below its 200-day moving average of $7.86.
Yearly Top and Bottom Value
RumbleOn’s stock is valued at $6.40 at 16:32 EST, way below its 52-week high of $13.52 and way above its 52-week low of $5.10.
More news about RumbleOn.
Stay up to date with our winners and losers daily report
